glp-1 obesity drug news today october 16 2025 2024 was a record year for trials and is already poised to take over Alarming rise in weight loss

Now, how does this happen

With gratitude, Jerry HAPPY MOTHERS DAY Happy Mothers Day to all those who celebrate

In addition, it is also critical that clinicians think about patient-specific risks

Antihistamines, decongestants, antidepressants, ACE inhibitors, beta-blockers, diuretics, and some pain medications all list dry mouth and increased thirst as side effects

Exclusive-Cigna drops coverage of GLP-1 obesity drugs for its own employees By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday

The FDA approved the companys IND on February 1, 2024, and Phase 1 trials will commence shortly